View on Pubmed.gov 33932986 | View on doi.org 10.1186/s12866-...
Comparative genome analysis of multidrug-resistant Pseudomonas aeruginosa JNQH-PA57, a clinically isolated mucoid strain with comprehensive carbapenem resistance mechanisms.
- Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China. Shandong Medicine and Health Key Laboratory of Laboratory Medicine, Jinan, Shandong, China.
- Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China.
- Shandong Medicine and Health Key Laboratory of Laboratory Medicine, Jinan, Shandong, China.
- Department of Clinical Laboratory Medicine, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China. wangeva-jiao@163.com. Shandong Medicine and Health Key Laboratory of Laboratory Medicine, Jinan, Shandong, China. wangeva-jiao@163.com.
Abstract
BACKGROUND
The prevalence of clinical multidrug-resistant (MDR) Pseudomonas aeruginosa has been increasing rapidly worldwide over the years and responsible for a wide range of acute and chronic infections with high mortalities. Although hundreds of complete genomes of clinical P. aeruginosa isolates have been sequenced, only a few complete genomes of mucoid strains are available, limiting a comprehensive understanding of this important group of opportunistic pathogens. Herein, the complete genome of a clinically isolated mucoid strain P. aeruginosa JNQH-PA57 was sequenced and assembled using Illumina and Oxford nanopore sequencing technologies. Genomic features, phylogenetic relationships, and comparative genomics of this pathogen were comprehensively analyzed using various bioinformatics tools. A series of phenotypic and molecular-genetic tests were conducted to investigate the mechanisms of carbapenem resistance in this strain.
RESULTS
Several genomic features of MDR P. aeruginosa JNQH-PA57 were identified based on the whole-genome sequencing. We found that the accessory genome of JNQH-PA57 including several prophages, genomic islands, as well as a PAPI-1 family integrative and conjugative element (ICE), mainly contributed to the larger genome of this strain (6,747,067 bp) compared to other popular P. aeruginosa strains (with an average genome size of 6,445,223 bp) listed in Pseudomonas Genome Database. Colony morphology analysis and biofilm crystal staining assay respectively demonstrated an enhanced alginate production and a thicker biofilm formation capability of JNQH-PA57. A deleted mutation at nt 424 presented in mucA gene, resulted in the upregulated expression of a sigma-factor AlgU and a GDP mannose dehydrogenase AlgD, which might explain the mucoid phenotype of this strain. As for the carbapenem resistance mechanisms, our results revealed that the interplay between impaired OprD porin, chromosomal β-lactamase OXA-488 expression, MexAB-OprM and MexXY-OprM efflux pumps overexpression, synergistically with the alginates-overproducing protective biofilm, conferred the high carbapenem resistance to P. aeruginosa JNQH-PA57.
CONCLUSION
Based on the genome analysis, we could demonstrate that the upregulated expression of algU and algD, which due to the truncation variant of MucA, might account for the mucoid phenotype of JNQH-PA57. Moreover, the resistance to carbapenem in P. aeruginosa JNQH-PA57 is multifactorial. The dataset presented in this study provided an essential genetic basis for the comprehensive cognition of the physiology, pathogenicity, and carbapenem resistance mechanisms of this clinical mucoid strain.
References
Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19830-5
APMIS. 2005 Mar;113(3):187-96
Microbiology (Reading). 1999 Jun;145 ( Pt 6):1349-1357
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
Cited by 14 citations (total)
Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
In host evolution of beta lactam resistance during active treatment for bacteremia.
Electronic publication date September 18, 2023
Natasha Spottiswoode [...] Charles R Langelier et al.
Multidrug-resistant (MDR) has been declared a serious threat by the United States Centers for Disease Control and Prevention. Here,...
Journal Article Review
The Revival of Aztreonam in Combination with Avibactam against Metallo-β-Lactamase-Producing Gram-Negatives: A Systematic Review of In Vitro Studies and Clinical Cases.
Electronic publication date August 28, 2021
Carola Mauri [...] Luigi Principe et al.
Infections caused by metallo-β-lactamase (MBL)-producing and are increasingly reported worldwide and are usually associated with high mortality rates...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
Substances
- •
- •